HPV-16 RNA processing

Frontiers in Bioscience

Volumn 13, Issue 15, 2008, Pages 5880-5891

  Schwartz, Stefan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Enhancer; HPV; Polyadenylation; PTB; Review; Silencer; Splicing

Indexed keywords

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

MESSENGER RNA; MICRORNA; VIRUS RNA;

ALTERNATIVE RNA SPLICING; GENE EXPRESSION REGULATION; GENETICS; GENOMIC INSTABILITY; GROWTH, DEVELOPMENT AND AGING; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; REVIEW; RNA PROCESSING; VIRUS GENOME;

ALTERNATIVE SPLICING; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; GENOMIC INSTABILITY; HUMAN PAPILLOMAVIRUS 16; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA, VIRAL;

EID: 52049104181     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3123     Document Type: Article

References (92)

1. Howley, P. M. & D. R. Lowy: Papillomaviridae and their replication. In: Virology. Eds: B. N. Fields, D. M. 2.Knipe&P. M. Howley. Lippincott/The Williams & Wilkins Co. Philadelphia, Pa, (2001)
2. zur Hausen, H.: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-350 (2002) (Pubitemid 37328947)
3. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard & H. zur Hausen: Classification of papillomaviruses. Virology, 324, 17-27 (2004) (Pubitemid 38737395)
4. de Sanjosé, S., M. Diaz, X. Castellsagué, G. Clifford, L. Bruni, N. Muñoz & F. X. Bosch: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect. Dis., 7, 453-459 (2007) (Pubitemid 46962343)
5. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders & C. J. Meijer: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27 (2003) (Pubitemid 36159887)
6. Hebner, C. M. & L. A. Laimins: Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol, 16, 83-97 (2006)
7. Doorbar, J.: The papillomavirus life cycle. J Clin Virol, 32 Suppl 1, S7-15 (2005) (Pubitemid 40332584)
8. Münger, K. & P. Howley: Human papillomavirus immortalization and transformation functions. Virus Res, 89, 213-228 (2002) (Pubitemid 35351540)
9. Baker, C. & C. Calef: Maps of papillomavirus mRNA transcripts. In: Human papillomaviruses: A compilation and analysis of nucleic acid and amino acid sequences. Eds: S. R. Billakanti, C. E. Calef, A. D. Farmer, A. L. Halpern&G. L. Myers. Theoretical biology and biophysics, Los Alamos National Laboratory, Los Almos (1997)
10. Norrild, B., C. H. Hansen & J. A. Glahder: Identification and activity of promoters in the HPV genome. In: Human papillomavirus gene regulation and transformation. Ed: B. Norrild. Transworld Research Network, (2007)
11. Baker, C. C.: Posttranscriptional regulation of papillomavirus gene expression. In: Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences. Eds: S. R. Billakanti, C. E. Calef, A. D. Farmer, A. L. Halpern&G. L. Myers. Theoretical biology and biophysics, Los Alamos national laboratory, Los Alamos (1997)
12. Zheng, Z. M. & C. C. Baker: Papillomavirus genome structure, expression, and posttranscriptional regulation. Front. Biosci., 11, 2286-2302 (2006) (Pubitemid 43822560)
13. Schwartz, S., M. Somberg, X. Zhao, M. Rush, D. Öberg, H. Cassidy, J. Fay & H. Lambkin: Regulation of HPV gene splicing and expression. In: Human papillomavirus gene regulation and transformation. Ed: B. Norrild. Transworld Research Network, (2007)
14. Schiffman, M. & S. K. Kjaer: Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr14-9 (2003)
15. Pett, M. & N. Coleman: Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J. Pathol., 212, 356-367 (2007) (Pubitemid 47099012)
16. Duensing, S. & K. Münger: Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int. J. Cancer, 109, 317-326 (2004)
17. Doorbar, J., A. Parton, K. Hartley, L. Banks, T. Crook, M. Stanley & L. Crawford: Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology, 178, 254-262 (1990) (Pubitemid 20276690)
18. Grassmann, K., B. Rapp, H. Maschek, K. U. Petry & T. Iftner: Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J Virol, 70, 2339-2349. (1996)
19. Milligan, S. G., T. Veerapraditsin, B. Ahamet, S. Mole & S. V. Graham: Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cell. Virology, 360, 172-181 (2007) (Pubitemid 46335715)
20. Ozbun, M. A. & C. Meyers: Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol, 71, 5161-5172. (1997) (Pubitemid 27258188)
21. Poppelreuther, S., T. Iftner & F. Stubenrauch: A novel splice donor at nt 1534 is required for long-term maintenance of HPV-31 genomes. Virology, 370, 93-101, (2007) (Pubitemid 350186042)
22. Zhao, X., M. Rush & S. Schwartz: Identification of an hnRNP A1 dependent splicing silencer in the HPV-16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol., 78, 10888-10905 (2004) (Pubitemid 39299629)
23. Rush, M., X. Zhao & S. Schwartz: A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J. Virol., 79, 12002-12015 (2005) (Pubitemid 41279317)
24. Somberg, M., X. Zhao, M. Fröhlich, M. Evander & S. Schwartz: PTB induces HPV-16 late gene expression by interfering with splicing inhibitory elements at the major late 5'-splice site SD3632. J. Virol., 81, in press (2008)
25. Belaguli, N. S., M. M. Pater & A. Pater: Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA. J Med Virol, 47, 445-53 (1995) (Pubitemid 26019003)
26. Zheng, Z. M., M. Tao, K. Yamanegi, S. Bodaghi & W. Xiao: Splicing of a cap-proximal human papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5' cap. J Mol Biol., 337, 1091-1108 (2004) (Pubitemid 38445053)
27. De la Rosa-Rios, M. A., M. Martínez-Salazar, M. Martínez-Garzia, C. Gonzaléz-Bonilla & N. Villegas- Sepúlveda: The intron of HPV-16 has a suboptimal branch point at a guanosine. Virus Res, 118, 46-54 (2006)
28. Stacey, S. N., D. Jordan, P. J. F. Snijders, M. Mackett, J. M. M. Walboomers & J. R. Arrand: Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J. Virol., 69, 7023-7031 (1995)
29. Tang, S., M. Tao, J. P. McCoy & Z.-M. Zheng: The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16-or 18-positive cervical cancer cell lines via translation reinitiation. J. Virol., 80, 4249-4263 (2006)
30. Remm, M., A. Remm & M. Ustav: Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism. J.Virol., 73, 3062-3070 (1999) (Pubitemid 29135695)
31. Hubert, W. G. & L. A. Laimins: Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J. Virol., 76, 2263-2273 (2002) (Pubitemid 34150694)
32. Filippova, M., M. M. Johnson, M. Bautista, V. Filippov, N. Fodor, S. S. Tungteakkhun, K. Williams & P. J. Duerksen-Hughes: The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J. Virol., 81, 4116-4129 (2007) (Pubitemid 46586906)
33. Pim, D., P. Massimi & L. Banks: Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene, 15, 257-64 (1997) (Pubitemid 27370872)
34. Ozbun, M. A.: Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription. J. Virol., 76, 11291-11300 (2002) (Pubitemid 35231284)
35. Zhao, X., D. Öberg, M. Rush, J. Fay, H. Lambkin & S. Schwartz: A 57 nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFIP1, CstF-64, hnRNP C1/C2 and PTB. J. Virol., 79, 4270-4288 (2005) (Pubitemid 40388365)
36. Ordonez, R. M., A. M. Espinosa, D. J. Sanchez-Gonzalez, J. Armendariz-Borunda & J. Berumen: Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J. Gen. Virol., 85, 1433-1444 (2004) (Pubitemid 38811424)
37. Klumpp, D., F. Stubenrauch & L. A. Laimins: Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus 31 on stable and transient viral replication. J. Virol., 71, 8186-8194 (1997) (Pubitemid 27449815)
38. Deng, W., G. Jin, B. Y. Lin, B. A. Van Tine, T. R. Broker & L. T. Chow: mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol, 77, 10213-26 (2003) (Pubitemid 37129665)
39. Mannik, A., K. Runkorg, N. Jaanson, M. Ustav & E. Ustav: Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo. J. Virol., 76, 5835-5845 (2002) (Pubitemid 34517936)
40. Kozak, M.: Regulation of translation initiation in eucaryotic systems. Annu. Rev. Cell Biol., 8, 197-225 (1992) (Pubitemid 23000996)
41. Tomita, Y. & B. Simizu: Translational properties of the human papillomavirus type-6 L1-coding mRNA. Gene, 133, 223-225 (1993)
42. Zhao, X., J. Fay, H. Lambkin & S. Schwartz: Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology, 369, 351-363 (2007) (Pubitemid 350087190)
43. Collier, B., D. Öberg, X. Zhao & S. Schwartz: Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J Virol, 76, 2739-2752 (2002) (Pubitemid 34184860)
44. Zhao, X. & S. Schwartz: Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region. Virus Genes, 36, 45-53, (2007) (Pubitemid 351195191)
45. Öberg, D., B. Collier, X. Zhao & S. Schwartz: Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol., 77, 11674-11684 (2003) (Pubitemid 37271666)
46. Rollman, E., L. Arnheim, B. Collier, D. Öberg, H. Hall, J. Klingström, J. Dillner, D. V. Pastrana, C. B. Buck, J. Hinkula, B. Wahren & S. Schwartz: HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology, 322, 182-189 (2004) (Pubitemid 38519879)
47. Zhou, W., R. F. Cook, S. J. Cook, S. A. Hammond, K. Rushlow, N. N. Ghabrial, S. L. Beger, R. C. Montelaro & C. J. Issel: Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV). Veterinary Micorbiol, 88, 127-151 (2002) (Pubitemid 34804786)
48. Taniguchi, I., K. Masuyama & M. Ohno: Role of purine-rich exonic splicing enhancers in nuclear retention of pre-mRNAs. Proc Natl Acad Sci U S A, 104, 13684-9 (2007) (Pubitemid 350003381)
49. Andrew, E. M. & D. DiMaio: Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed cells. J. Virol., 67, 7705-7710 (1993)
50. Terhune, S. S., W. G. Hubert, J. T. Thomas & L. A. Laimins: Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J. Virol., 75, 8147-8157 (2001) (Pubitemid 32743687)
51. Terhune, S. S., C. Milcarek & L. A. Laimins: Regulation of human papillomavirus 31 polyadenylation during the differentiation-dependent life cycle. J. Virol., 73, 7185-7192 (1999) (Pubitemid 29383199)
52. Öberg, D., B. Collier, X. Zhao & S. Schwartz: A downstream polyadenylation element in human papillomavirus type 16 encodes multiple GGG-motifs and interacts with hnRNP H. J Virol, 79, 9254-9269 (2005) (Pubitemid 40934837)
53. Baker, C. C. & J. S. Noe: Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells. J. Virol., 63, 3529-3534 (1989) (Pubitemid 19181418)
54. Furth, P. A. & C. C. Baker: An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J Virol, 65, 5806-5812. (1991)
55. Furth, P. A., W. T. Choe, J. H. Rex, J. C. Byrne & C. C. Baker: Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol, 14, 5278-5289. (1994)
56. Gunderson, S. I., M. Polycarpou-Schwarz & I. W. Mattaj: U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly (A) polymerase. Molecular Cell, 1, 255-264 (1998) (Pubitemid 128378666)
57. Cumming, S. A., M. G. McPhillips, T. Veerapraditsin, S. G. Milligan & S. V. Graham: Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex. J. Virol., 77, 5167-5177 (2003) (Pubitemid 36460931)
58. Goraczniak, R. & S. I. Gunderson: The regulatory element in the 3' untranslated region of human papillomavirus 16 inhibits expression by binding CUG binding protein 1. J. Biol. Chem, 283: 2286-96 (2007)
59. Sokolowski, M., W. Tan, M. Jellne & S. Schwartz: mRNA instability elements in the human papillomavirus type 16 L2 coding region. J Virol, 72, 1504-1515. (1998) (Pubitemid 28116939)
60. Mori, S., S. Ozaki, T. Yasugi, H. Yoshikawa, Y. Taketani & T. Kanda: Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells. Mol. Cell. Biochem., 288, 47-57 (2006) (Pubitemid 44314439)
61. Tan, W., B. K. Felber, A. S. Zolotukhin, G. N. Pavlakis & S. Schwartz: Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J Virol, 69, 5607-5620. (1995)
62. Berg, M., J. DiFatta, E. Hoiczyk, R. Schlegel & G. Ketner: Viable adenovirus vaccine prototypes: Highlevel production of a papillomavirus capsid antigen from the major late transcription unit. Proc Natl Acad Sci U S A, 102, 4590-4595 (2005) (Pubitemid 40397156)
63. Barreau, C., L. Paillard & H. B. Osborne: AU-rich elements and associated factors: are there unifying principles? Nucleic Acids. Res., 33, 7138-7150 (2006)
64. Jeon, S., B. L. Allen-Hoffmann & P. F. Lambert: Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J.Virol, 69, 2989-2997 (1995)
65. Jeon, S. & P. F. Lambert: Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc Natl Acad Sci U S A, 92, 1654-1658 (1995)
66. Zhao, C., W. Tan, M. Sokolowski & S. Schwartz: Identification of nuclear and cytoplasmic factors that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3' untranslated region of human papillomavirus type 1 late mRNAs. J Virol, 70, 3659-3667 (1996)
67. Vinther, J., M. W. Rosenstierne, K. Kristiansen & B. Norrild: The 3' region of human papillomavirus type 16 early mRNAs decrease expression. BMC Infect. Dis., 5, 83 (2005)
68. Kennedy, I. M., J. K. Haddow & J. B. Clements: Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo. J Virol, 64, 1825-1829. (1990) (Pubitemid 20104924)
69. Kennedy, I. M., J. K. Haddow & J. B. Clements: A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol, 65, 2093-2097. (1991)
70. Cheunim, T., J. Zhang, S. G. Milligan, M. G. McPhilips & S. V. Graham: The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res, in press, (2007)
71. Koffa, M. D., S. V. Graham, Y. Takagaki, J. L. Manley & J. B. Clements: The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc Natl Acad Sci U S A, 97, 4677-4682. (2000) (Pubitemid 30238617)
72. Dietrich-Goetz, W., I. M. Kennedy, B. Levins, M. A. Stanley & J. B. Clements: A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. Proc Natl Acad Sci U S A, 94, 163-168. (1997) (Pubitemid 27027180)
73. McPhillips, M. G., T. Veerapraditsin, S. A. Cumming, D. Karali, S. G. Milligan, W. Boner, I. M. Morgan & S. V. Graham: SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J Virol, 78, 10598-10605 (2004) (Pubitemid 39258386)
74. Zhao, X., M. Rush, A. Carlsson & S. Schwartz: The presence of inhibitory RNA elements in the late 3'-untranslated region is a conserved property of human papillomaviruses. Virus Res., 125, 135-144 (2007) (Pubitemid 46589674)
75. Sokolowski, M., C. Zhao, W. Tan & S. Schwartz: AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene, 15, 2303-2319. (1997) (Pubitemid 27496981)
76. Tan, W. & S. Schwartz: The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region. J Virol, 69, 2932-2945. (1995)
77. Wiklund, L., M. Sokolowski, A. Carlsson, M. Rush & S. Schwartz: Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability in the HPV-1 late 3' untranslated region. J Biol Chem, 277, 40462-40471 (2002) (Pubitemid 35215623)
78. Sokolowski, M., H. Furneaux & S. Schwartz: The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein. J Virol, 73, 1080-1091. (1999) (Pubitemid 29036759)
79. Zhao, C., M. Sokolowski, W. Tan & S. Schwartz: Characterisation and partial purification of cellular factors interacting with a negative element on human papillomavirus type 1 late mRNAs. Virus Res, 55, 1-13 (1998) (Pubitemid 28310719)
80. Sokolowski, M. & S. Schwartz: Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element. Virus Res, 73, 163-175. (2001) (Pubitemid 32141251)
81. Felber, B. K. & G. N. Pavlakis: Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression. AIDS, 7, S51-62 (1993) (Pubitemid 23179837)
82. Pollard, V. W. & M. H. Malim: The HIV-1 Rev protein. Annu Rev Microbiol, 52, 491-532 (1998) (Pubitemid 28481200)
83. Carlsson, A. & S. Schwartz: Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm. Arch Virol, 145, 491-503 (2000) (Pubitemid 30172071)
84. Collier, B., L. Goobar-Larsson, M. Sokolowski & S. Schwartz: Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly (rC)-binding proteins 1 and 2. J Biol Chem, 273, 22648-56. (1998) (Pubitemid 28399835)
85. Ostareck, D. H., A. Ostareck-Lederer, I. N. Shatsky & M. W. Hentze: Lipoxygenase mRNA silencing in erythroid differentiation: The 3'UTR regulatory complex controls 60S ribosomal subunit joining. Cell, 104, 281-290 (2001) (Pubitemid 32174843)
86. Gu, W., M. Li, W. M. Zhao, N. X. Fang, S. Bu, I. H. Frazer & K.-N. Zhao: tRNASer (CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Res, 32, 4448-4461 (2004) (Pubitemid 39317723)
87. Disbrow, G. L., I. Sunitha, C. C. Baker, J. Hanover & R. Schlegel: Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology, 311, 105-114 (2003) (Pubitemid 36794215)
88. Lin, C.-T., Y.-C. Tsai, L. He, R. Calizo, H.-H. Chou, T.-C. Chang, Y.-K. Soong, C.-F. Hung & C.-H. Lai: A DNA vaccine encoding a codon-optimised human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. J. Biomed. Sci., 13, 481-488 (2006)
89. Cid-Arregui, A., V. Juarez & H. zur Hausen: A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol, 77, 4928-4937 (2003) (Pubitemid 36402841)
90. Liu, W. J., F. Gao, K. N. Zhao, W. Zhao, G. J. Fernando, R. Thomas & I. H. Frazer: Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology, 301, 43-52 (2002) (Pubitemid 35168500)
91. Cai, X., G. Li, L. A. Laimins & B. R. Cullen: Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J. Virol., 80, 10890-10893 (2006) (Pubitemid 44628938)
92. Martinez, I., A. S. Gardiner, K. F. Board, F. A. Monzon, R. P. Edwards & S. A. Khan: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene, in press, (2007)